SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower following the government's proposal for an unexpectedly minimal increase in 2027 Medicare Advantage payment rates, sparking broad concerns across the health insurance sector. While many view the significant sell-off as an overreaction and a long-term buying opportunity due to strong fundamentals, others anticipate further declines, highlighting policy risk and the ongoing political scrutiny on healthcare profitability.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending due to its recent surge to new all-time highs, fueled by increasing geopolitical instability, a depreciating US Dollar, and heightened central bank demand for physical gold. The community is sharply divided, debating whether this parabolic move is a legitimate hedge against fiat currency debasement or a speculative 'mania' ripe for a significant pullback.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is capturing significant attention following its collaboration with Microsoft's AI Co-Innovation Labs to integrate advanced agentic AI into its ADAM robot, highlighting a pivotal development in the robotics sector. The community is actively discussing the potential for a sustained rally and short squeeze, though some express skepticism about the full impact of the partnership on the company's valuation.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is a major talking point as strong physical demand from global governments and industries like AI and EVs drives its significant rally, exacerbated by a weaker dollar. Community members are fiercely divided, with bulls anticipating a historic short squeeze due to supply deficits and alleged manipulation, while bears warn of an unsustainable bubble poised for a sharp correction.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is a hot topic as its earnings report approaches, with the early release date fueling strong community speculation about a significant new deal, potentially with a hyperscaler like Amazon or AWS. Investors are optimistic, anticipating IREN's strategic pivot to AI infrastructure will unlock substantial value given the high demand for GPU-centric data capacity. Many believe the company is well-positioned in the rapidly expanding AI cloud sector, despite discussions around its historical correlation to Bitcoin price movements.

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

GRI Bio Inc. is actively trending following its recent 1-for-28 reverse stock split, which has created an exceptionally low float of approximately 500k shares. This development, coupled with recently announced positive Phase 2a clinical data and secured funding, is driving intense community discussion: many anticipate a significant short squeeze comparing it to prior low-float runners, while others express deep skepticism citing the company's history of frequent dilutions and management's perceived lack of trustworthiness.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending amid growing community excitement fueled by recent institutional interest, including a notable ownership stake by Bank of Nova Scotia and increased ETF allocations. Investors are eagerly anticipating significant "contract news" for its high-performance computing (HPC) data centers, hoping to see the company re-rated as a pure-play AI infrastructure provider rather than solely a Bitcoin miner. This anticipation is driving discussions around its potential to lead in the energy-intensive computing sector.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is generating significant buzz following analyst endorsements recognizing its AI/HPC colocation strategy and major contracts with hyperscalers. The community highlights strong institutional interest and buying pressure, viewing the stock as increasingly driven by its data center expansion rather than solely by Bitcoin's fluctuations, with many anticipating substantial upside.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending as a major beneficiary of the AI-driven data storage boom, with the community actively discussing how the insatiable demand from hyperscale data centers is transforming the memory and storage sector. Recent analyst upgrades and significant price target increases reflect growing confidence in its strategic focus on high-capacity solutions like HAMR technology, positioning it as a key player in the AI infrastructure buildout.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments faces significant downward pressure following analyst downgrades, notably from Goldman Sachs to "Sell" with a reduced price target. This bearish sentiment is compounded by China's anti-dumping probe into U.S. analog chips and recent Q3 earnings that, despite a revenue beat, offered a cautious outlook. The community widely discusses the stock's lagging performance relative to the broader semiconductor sector and its limited direct exposure to current AI-driven market excitement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PepGen (NASDAQ:PEPG) Trading Down 2.6% - What's Next?

PepGen (NASDAQ:PEPG) Stock Price Down 2.6% - Time to Sell...

PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of "Moderate Buy" by Brokerages

PepGen, Inc. (NASDAQ:PEPG - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the stock, Marketbeat Ratings...

PepGen (NASDAQ:PEPG) Reaches New 12-Month High - What's Next?

PepGen (NASDAQ:PEPG) Sets New 12-Month High - Time to Buy...

PepGen Sees Unusually High Options Volume (NASDAQ:PEPG)

PepGen, Inc. (NASDAQ:PEPG - Get Free Report) was the target of unusually large options trading on Friday. Traders bought 8,010 call options on the company. This represents an increase of 649...

How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44%

The mean of analysts' price targets for PepGen (PEPG) points to a 75.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...

PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Hold" by Analysts

PepGen, Inc. (NASDAQ:PEPG - Get Free Report) has received a consensus rating of "Hold" from the six analysts that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the...

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

Sarepta's Stock Rises on Positive Updates on DM1 Therapy

SRPT's stock jumps as its SRP-1003 study advances with a positive safety review and new dosing cohorts underway.

FY2025 EPS Estimates for PepGen Lifted by Leerink Partnrs

PepGen, Inc. (NASDAQ:PEPG - Free Report) - Research analysts at Leerink Partnrs boosted their FY2025 earnings per share estimates for shares of PepGen in a research note issued to investors on...

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

PEPG
PepGen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PEPG News

PEPGPepGen Inc